• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3360.0
  • ISIN : INE198H01019
66.95 1 (2.00%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    66.95

  • Today’s High

    66.95

  • Open

    66.95

  • Perv Close

    65.64

  • 52W Low

    31.35

  • 52W High

    74.80

Key Indicators

  • P/E(TTM)

    47.15

  • Mar.Cap (₹Cr.)

    189.83

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.95

  • Debt-Equity Ratio

    2.00

  • AGM Date

    01-Aug-2025

  • EPS

    1.42

  • P/E Ratio

    47.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    189.83

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.35

  • BV (₹)

    48.90

  • Sales( ₹ in Cr.)

    473.94

  • NP (in Cr.)

    4.02

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    2.10

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    189.83

  • 52 Week High

    74.80

  • 52 Week Low

    31.35

  • Price BSE

    67.0

  • Price NSE

    67.00

  • Market Capital( in Cr.)

    189.83

  • P/C Ratio

    31.80

  • P/E Ratio

    47.20

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 395.62 418.96 492.76 348.42 300.09 354.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 395.62 418.96 492.76 348.42 300.09 354.74
Other Income 6.96 2.73 2.67 7.01 6.69 4.34
Stock Adjustments 5.86 15.14 -4.77 1.46 -4.25 6.48
Total Income 408.44 436.83 490.66 356.89 302.53 365.56
EXPENDITURE :            
Raw Materials 387.76 418.98 461.35 335.96 285.93 347.45
Power and Fuel Cost 0.03 0.03 0.04 0.00 0.01 0.04
Employee Cost 0.54 0.63 0.67 0.20 0.29 0.37
Other Manufacturing Expenses 0.60 1.50 7.15 4.99 1.31 1.65
Selling and Administration Expenses 7.83 4.52 6.89 3.88 4.94 3.82
Miscellaneous Expenses 0.26 0.71 0.50 0.20 0.12 0.01
Employee Benefit Expenses 0.54 0.63 0.67 0.20 0.29 0.37
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 397.03 426.37 476.60 345.23 292.61 353.33
Operating Profit 11.42 10.45 14.07 11.66 9.93 12.22
Interest 4.38 2.87 2.04 2.44 1.79 2.23
Gross Profit 7.04 7.58 12.03 9.22 8.14 9.99
Depreciation 1.70 1.57 1.99 0.92 0.89 1.01
Profit Before Tax 5.34 6.01 10.04 8.30 7.25 8.98
Current Tax 1.33 2.28 3.59 1.66 1.50 2.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.67 -0.04 -0.11 0.12 -0.05 0.19
Reported Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Adjustment below Net Profit 0.00 0.00 -0.01 0.00 0.00 0.00
P & L Balance brought forward 48.42 44.65 38.11 31.59 25.80 19.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.23
P & L Balance carried down 53.11 48.42 44.65 38.11 31.59 25.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 1.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.10
Earnings Per Share-Unit Curr 1.67 1.49 2.58 2.79 2.48 2.80
Earnings Per Share(Adj)-Unit Curr 1.67 1.49 2.58 2.79 2.48 2.80
Book Value 45.57 44.43 43.85 41.29 38.50 36.02
Book Value(Adj)-Unit Curr 45.57 44.43 43.85 41.29 38.50 36.02

Shareholding Pattern

  • Promoter Group

    44.80%

  • Public Share Holding

    55.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,682,443 30.62 8,682,443 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 4,020,000 14.18 4,020,000 2
Sub Total 12,702,443 44.80 12,702,443 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 559,217 1.97 559,217 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 559,217 1.97 559,217 2
2] Non Institution
Bodies Corporate 955,376 3.37 933,896 86
Clearing Members 1,270 0.00 1,270 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 234,179 0.83 234,179 101
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 640,561 2.26 640,561 229
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,447,300 26.27 7,447,300 90
Individuals holding nominal share capital up to Rs. 1 lakh 5,765,796 20.33 5,275,477 15,276
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,092,643 53.23 14,580,844 15,787
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,354,303 100.00 27,842,504 15,796

Company Background

Aarey Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarey Drugs & Pharmaceuticals Ltd
  • BSE Code : 3360.0
  • ISIN : INE198H01019

  • Incorporation Year

    1990

  • Registered Office

    E-34 MIDC Tarapur
    Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-23455543

  • FAX

  • Chairman

    Mihir R Ghatalia

  • Managing Director

    Mihir R Ghatalia

  • Company Secretary

    KAILASH CHAND JETHLIA

  • Auditor

    Motilal & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarey Drugs 66.95 402.58 395.62 47.15 6.09
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10